Management of Prostate Cancer in Central China
|ClinicalTrials.gov Identifier: NCT01614548|
Recruitment Status : Completed
First Posted : June 8, 2012
Last Update Posted : June 8, 2012
Some recent reports indicate that incidence of prostate cancer is increasing rapidly in China. However, no large-scale survey of prostate cancer has been done in central China, few data are available regarding its management. The investigators aimed to analyze the management of prostate cancer and compare the outcome of patients with such a survey.
The investigators collected data of patients diagnosed with prostate cancer from the 2003 and 2008 in central China. Data were disaggregated by rural and urban hukou. The survival rate of patients was analyzed using Kaplan-Meier method. Prognostic factors were analyzed using the log-rank test and Cox proportional hazards model.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||789 participants|
|Official Title:||Comparisons of Management and Outcome of Prostate Cancer in Central China Between 2003 and 2008: A Multi-institutional Report|
|Study Start Date :||January 2003|
|Primary Completion Date :||December 2011|
|Study Completion Date :||December 2011|
We selected 9 cities (Zhengzhou, Luoyang, Kaifeng, Anyang, Xinyang, Zhoukou, Shangqiu, Nanyang, Zhumadian) by probability proportional to size sampling from geographical regions in central China. All cases with complete follow-up data of histological-proven prostate cancer treated in 2003 and 2008 at 14 department of urology in the 9 cities were retrospectively collected. Only patients with newly diagnosed prostate cancer were included in the study. Those with a history of prostate cancer who were treated for another disease were excluded from study.
- overall survival [ Time Frame: 3 years ]overall survival that was defined as the interval from the date of diagnosis to the Medicare date of death
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01614548
|the first affiliated hospital of Zhengzhou University|
|Zhengzhou, Henan, China, 450052|
|Principal Investigator:||Liu Bingqian, Ph.D MD||The First Affiliated Hospital of Zhengzhou University|